Page last updated: 2024-08-25

s20098 and Fibromyalgia

s20098 has been researched along with Fibromyalgia in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	4 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bruno, A; Caminiti, M; Cogliandro, N; Lorusso, S; Micò, U; Muscatello, MR; Pandolfo, G; Zoccali, RA	1
Calandre, EP; Garcia-Leiva, JM; Rico-Villademoros, F; Rodriguez-Lopez, CM; Slim, M; Torres, P	1
Campanella, D; De Bartolomeis, A; De Berardis, D; Di Giannantonio, M; Di Nicola, M; Fornaro, M; Iasevoli, F; Martinotti, G; Mazza, M; Olivieri, L; Perna, G; Rapini, G; Serroni, N; Srinivasan, V; Tomasetti, C; Valchera, A	1
Levin, IaI	1

Reviews

1 review(s) available for s20098 and Fibromyalgia

Article	Year
Agomelatine beyond borders: current evidences of its efficacy in disorders other than major depression. International journal of molecular sciences, 2015, Jan-05, Volume: 16, Issue:1 Topics: Acetamides; Antidepressive Agents; Bipolar Disorder; Depressive Disorder; Fibromyalgia; Humans; Migraine Disorders; Receptor, Melatonin, MT1; Receptor, Melatonin, MT2; Receptor, Serotonin, 5-HT2C; Schizophrenia; Sleep Wake Disorders	2015

Article

Year

Agomelatine beyond borders: current evidences of its efficacy in disorders other than major depression.

International journal of molecular sciences, 2015, Jan-05, Volume: 16, Issue:1

Topics: Acetamides; Antidepressive Agents; Bipolar Disorder; Depressive Disorder; Fibromyalgia; Humans; Migraine Disorders; Receptor, Melatonin, MT1; Receptor, Melatonin, MT2; Receptor, Serotonin, 5-HT2C; Schizophrenia; Sleep Wake Disorders

2015

Trials

2 trial(s) available for s20098 and Fibromyalgia

Article	Year
Agomelatine in the treatment of fibromyalgia: a 12-week, open-label, uncontrolled preliminary study. Journal of clinical psychopharmacology, 2013, Volume: 33, Issue:4 Topics: Acetamides; Affect; Analgesics; Antidepressive Agents; Anxiety; Chronic Pain; Cognition; Depression; Executive Function; Female; Fibromyalgia; Humans; Middle Aged; Neuropsychological Tests; Pain Measurement; Pilot Projects; Psychiatric Status Rating Scales; Time Factors; Treatment Outcome	2013
Agomelatine for the treatment of patients with fibromyalgia and depressive symptomatology: an uncontrolled, 12-week, pilot study. Pharmacopsychiatry, 2014, Volume: 47, Issue:2 Topics: Acetamides; Adult; Depressive Disorder; Female; Fibromyalgia; Follow-Up Studies; Humans; Male; Middle Aged; Pilot Projects; Serotonin Antagonists; Treatment Outcome	2014

Article

Year

Agomelatine in the treatment of fibromyalgia: a 12-week, open-label, uncontrolled preliminary study.

Journal of clinical psychopharmacology, 2013, Volume: 33, Issue:4

Topics: Acetamides; Affect; Analgesics; Antidepressive Agents; Anxiety; Chronic Pain; Cognition; Depression; Executive Function; Female; Fibromyalgia; Humans; Middle Aged; Neuropsychological Tests; Pain Measurement; Pilot Projects; Psychiatric Status Rating Scales; Time Factors; Treatment Outcome

2013

Agomelatine for the treatment of patients with fibromyalgia and depressive symptomatology: an uncontrolled, 12-week, pilot study.

Pharmacopsychiatry, 2014, Volume: 47, Issue:2

Topics: Acetamides; Adult; Depressive Disorder; Female; Fibromyalgia; Follow-Up Studies; Humans; Male; Middle Aged; Pilot Projects; Serotonin Antagonists; Treatment Outcome

2014

Other Studies

1 other study(ies) available for s20098 and Fibromyalgia

Article	Year
[Clinical experience in using agomelatin (valdoxan) in the neurological practice]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2011, Volume: 111, Issue:11 Pt 1 Topics: Acetamides; Aged; Benzodiazepines; Depression; Female; Fibromyalgia; Humans; Hypnotics and Sedatives; Male; Middle Aged; Migraine Disorders; Sleep Initiation and Maintenance Disorders; Stroke; Withholding Treatment	2011